Public Employees Retirement Association of Colorado Reduces Holdings in HCA Healthcare, Inc. $HCA

Public Employees Retirement Association of Colorado decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 11.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 20,116 shares of the company’s stock after selling 2,690 shares during the period. Public Employees Retirement Association of Colorado’s holdings in HCA Healthcare were worth $9,391,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in HCA. Nordea Investment Management AB boosted its position in shares of HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after purchasing an additional 108,849 shares during the period. Hudson Bay Capital Management LP boosted its position in shares of HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after purchasing an additional 2,849 shares during the period. Nomura Asset Management Co. Ltd. boosted its position in shares of HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares during the period. Advisors Capital Management LLC boosted its position in shares of HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC boosted its position in HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after buying an additional 8,733 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.8%

Shares of HCA opened at $390.09 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The firm’s fifty day simple moving average is $427.96 and its 200-day simple moving average is $472.40. The firm has a market capitalization of $86.54 billion, a price-to-earnings ratio of 13.41, a PEG ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the prior year, the business earned $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Analysts Set New Price Targets

Several brokerages have commented on HCA. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research report on Thursday, June 4th. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Argus decreased their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Stephens reduced their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Finally, Robert W. Baird reduced their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.